Phaarmasia

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE486I01016
  • NSEID:
  • BSEID: 523620
INR
100.14
-0.89 (-0.88%)
BSENSE

Jun 10, 03:30 PM

BSE+NSE Vol: 4.37 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 93.72% vs -20.33% in Mar 2025

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 1,205.03% vs -205.77% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 193.03% vs -142.17% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 1,000.00% vs -50.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Phaarmasia With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
47.21
289.72
-242.51
-83.70%
Other Operating Income
0.00
0.00
0.00
Total Operating income
47.21
289.72
-242.51
-83.70%
Raw Material Cost
33.22
289.67
-256.45
-88.53%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.28
-6.62
6.90
104.23%
Employee Cost
2.89
2.28
0.61
26.75%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
8.95
6.53
2.42
37.06%
Total Expenditure (Excl Depreciation)
45.34
291.86
-246.52
-84.47%
Operating Profit (PBDIT) excl Other Income
1.87
-2.14
4.01
187.38%
Other Income
0.96
0.83
0.13
15.66%
Operating Profit (PBDIT)
2.83
-1.31
4.14
316.03%
Interest
0.22
0.96
-0.74
-77.08%
Exceptional Items
18.99
0.00
18.99
Gross Profit (PBDT)
21.60
-2.27
23.87
1,051.54%
Depreciation
0.21
0.72
-0.51
-70.83%
Profit Before Tax
21.39
-2.98
24.37
817.79%
Tax
3.82
0.33
3.49
1,057.58%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
17.57
-3.31
20.88
630.82%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
17.57
-3.31
20.88
630.82%
Equity Capital
6.83
3.09
3.74
121.04%
Face Value
10.00
10.00
0.00
Reserves
15.27
65.09
-49.82
-76.54%
Earnings per share (EPS)
25.72
-10.71
36.43
340.15%
Diluted Earnings per share
25.74
-10.72
36.46
340.11%
Operating Profit Margin (Excl OI)
3.96%
-0.74%
0.00
4.70%
Gross Profit Margin
45.75%
-0.78%
0.00
46.53%
PAT Margin
37.22%
-1.14%
0.00
38.36%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 47.21 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 93.72% vs -20.33% in Mar 2025

Annual - Standalone Net Profit
Standalone Net Profit 17.57 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 1,205.03% vs -205.77% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.87 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 193.03% vs -142.17% in Mar 2025

Annual - Interest
Interest 0.22 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 1,000.00% vs -50.00% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.96%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025